SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-15-000045
Filing Date
2015-02-09
Accepted
2015-02-06 19:36:03
Documents
4
Period of Report
2015-02-06
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM8-K rgbp20150206form8k.htm 8-K 25750
2 CONVERTIBLE PROMISSORY NOTE ISSUED TO LLC rgbp20150206form8kex10_1.htm EX-10.1 23608
3 CONVERTIBLE PROMISSORY NOTE ISSUED TO INDIVIDUAL INVESTOR rgbp20150206form8kex10_2.htm EX-10.2 23609
4 CONVERTIBLE PROMISSORY NOTE ISSUED TO DUNHILL ROSS rgbp20150206form8kex10_3.htm EX-10.3 24803
  Complete submission text file 0001607062-15-000045.txt   98847
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 15586394
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1